Morgan Stanley Ice Cure Medical Ltd. Call Options Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding ICCM
# of Institutions
16Shares Held
151KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA40.5KShares$48,1390.0% of portfolio
-
Xtx Topco LTD London, X021.9KShares$26,0320.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC18.9KShares$22,4610.0% of portfolio
-
Two Sigma Securities, LLC New York, NY17KShares$20,2240.0% of portfolio
-
Foundations Investment Advisors, LLC15KShares$17,8500.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $43.8M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.